Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation for GDM Prevention
NCT05208827Phase 1Unknown
- Sponsor
- Women's Hospital, Zhejiang University School of Medicine
- Start
- Jan 2022
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in gestational diabetes mellitus (GDM) comparing Vitamin D3 (1600 IU) with Placebo (2 arms). Primary endpoint: Gestational diabetes. Status: unknown.
02
Drugs
vitamin d
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT05208827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05208827.